EAU 2013 - Programme Book - YouMed

Sunday, 17 March - EAU Programme
Abstract Session
09.15 - 10.45 Renal tumour diagnosis: From new techniques to follow-up
Yellow Hall 1-2-3 - Level N1
Poster Session 29
Chairs: A. Cestari, Milan (IT)
J.M. De La Morena Gallego, Madrid (ES)
Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes
in length, followed by 2 minutes for discussion.
336 Sorafenib decreases Indium-111-girentuximab tumor uptake in clear cell renal cell carcinoma patients
C.H.J. Muselaers, O.C. Boerman, A.B. Stillebroer, I.M.E. Desar, M.J. Boers-Sonderen, C.M.L. Van Herpen,
J.F. Langenhuijsen, E. Oosterwijk, W.P.J. Leenders, W.J.G. Oyen, P.F.A. Mulders (Nijmegen, The Netherlands)
337 Clinicopathological characteristics of Xp11 translocation renal cell carcinoma in adults: Diagnosis using
FISH analysis in conjunction with TFE3 immunostaining
M. Hirobe, N. Masumori, T. Tanaka, H. Kitamura, A. Tonooka, T. Hasegawa, T. Tsukamoto (Sapporo, Japan)
338 Do small renal cell carcinomas have a higher prevalance of locally advanced growth and distant
metastases? A large multicentre study
S. Steffens, M. Janssen, F.C. Roos, F. Becker, S. Schumacher, R. Hofmann, G. Wegener, S. Siemer, M. Stöckle,
J.W. Thüroff, M. Schrader, K. Junker, M.A. Kuczyk, A.J. Schrader (Hanover, Homburg/Saar, Mainz, Homburg,
Ulm, Marburg, Germany)
339 Histopathological and molecular predictors of chronic kidney disease progression and its related mortality
after radical nephrectomy
T. Sejima, H. Iwamoto, T. Masago, S. Morizane, A. Yao, T. Isoyama, A. Takenaka (Yonago, Japan)
340 Independent validation of the 2010 TNM staging system for renal cell carcinoma: Does it improves
predictive accuracy in cancer-specific mortality compared to 2002 TNM?
M. Roscigno, S. Shariat, M. May, R. Zigeuner, T. Chromecki, C. Stief, L. Schips, O. De Cobelli, B. Rocco, C. De
Nunzio, B. Feciche, M. Truss, S. Pahernik, S. Zastrow, G. Novara, A. Minervini, A. Antonelli, V. Mirone,
A. Simonato, R. Bertini, V. Ficarra, S. Brookman-May (Bergamo, Vasto, Milan, Rome, Padua, Florence,
Brescia, Naples, Genova, Italy; New York, United States of America; Straubing, Munich, Dortmund,
Heidelberg, Dresden, Regensburg, Germany; Graz, Austria; Cluj-Napoca, Romania; Aalst, Belgium)
341 Interdisciplinary counseling service for renal malignancies: Patients and physicians view of a new model
of care
J. Huber, A. Ihrig, E. Winkler, C. Gruellich, P. Hallscheidt, M. Zeier, S. Pahernik, M. Hohenfellner (Heidelberg,
Germany)
342 Is it necessary to perform long term follow up in patients after surgery for renal cell carcinoma pT1 and
pT2?
S. Nestler (Mainz, Germany)
343 Prevalence of Computed Tomography (CT) detected solid renal masses: An update
S.L. Lee, L.T. Koh, K.K. Ng, F.C. Ng (Singapore, Singapore)
344 Preoperative decision-making for renal cell carcinoma: Cystic morphology in cross sectional imaging
predicts lower malignant potential
J. Huber, A. Winkler, T. Bruckner, W. Roth, P. Hallscheidt, K. Daneshvar, M. Hohenfellner, S. Pahernik
(Heidelberg, Germany)
EAU Milan 2013
159
Sunday